TITLE

Testosterone Replacement in Diabetes and the Metabolic Syndrome

AUTHOR(S)
Jones, T. H.
PUB. DATE
May 2011
SOURCE
Internal Medicine Alert;5/29/2011 Supplement, p80
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on the study conducted by T. H. Jones regarding the effects of testosterone (TST) 2% gel daily applications in hypogonadal men with type 2 diabetes (DM2) and metabolic syndrome (MBS).
ACCESSION #
61180816

 

Related Articles

  • ADAPTATION OF THE ENDOGENOUS INSULIN SECRETION IN NON-INSULIN-DEPENDENT DIABETES BY AN INDIVIDUAL SPORT THERAPEUTIC INTERVENTION -- A PILOT STUDY. Küpper, Thomas; Jacobson, Victoria; Müller, Sarah; Müller, Michael; Westphal, Carolin // Medicina Sportiva;2012, Vol. 16 Issue 4, p131 

    The article presents a pilot study which aimed to evaluate the effect of a multimodular therapy concept on proinsulin in patients with metabolic syndrome (MS) and non-insulin dependent diabetes. An overview of MS is provided with focus on peripheral insulin resistance as its specific problem....

  • Does metabolic syndrome worsen systolic dysfunction in diabetes? The shortwave study. Faganello, Giorgio; Cioffi, Giovanni; Faggiano, Pompilio; Candido, Riccardo; Tarantini, Luigi; Feo, Stefania; Lenarda, Andrea; Simone, Giovanni // Acta Diabetologica;Feb2015, Vol. 52 Issue 1, p143 

    Patients with metabolic syndrome (MetS) have high cardiovascular event rates. The additional effect of MetS on left ventricular (LV) systolic function in patients with type 2 diabetes mellitus (T2DM) is unknown. We studied the relation between MetS and LV systolic function in T2DM patients...

  • Health-Related Quality of Life in Relation to Obesity Grade, Type 2 Diabetes, Metabolic Syndrome and Inflammation. Slagter, Sandra N.; van Vliet-Ostaptchouk, Jana V.; van Beek, André P.; Keers, Joost C.; Lutgers, Helen L.; van der Klauw, Melanie M.; Wolffenbuttel, Bruce H. R. // PLoS ONE;10/16/2015, Vol. 10 Issue 10, p1 

    Background: Health-related quality of life (HR-QoL) may be compromised in obese individuals, depending on the presence of other complications. The aim of this study is to assess the effect of obesity-related conditions on HR-QoL. These conditions are i) grade of obesity with and without type 2...

  • Statins lower testosterone in diabetic men.  // Primary Care Reports;Jul2009 Clinical Briefs, Vol. 14 Issue 7, p14 

    The article discusses research being done on the relationship between statin therapy and reduced testosterone levels in diabetic men. It references a study by R. D. Stanworth et al in a 2009 issue of "Diabetes Care." In the study, type 2 diabetic men's total testosterone levels were compared in...

  • Clinical Briefs. Kuritzky, Louis // Internal Medicine Alert;6/29/2009, Vol. 31 Issue 12, p96 

    The article offers medical briefs in the U.S. Ramelteon is a melanocortin receptor agonist that is not a controlled substance and has a clear safety profile when used up to five weeks, indicating safety for insomnia. In a study of adult type 2 diabetic men, results showed that patients on...

  • CORRELATION BETWEEN SERUM LEVELS OF INSULIN-LIKE GROWTH FACTOR-1(IGF-1) WITH ESTROGEN AND FREE TESTOSTERONE LEVELS IN OBESE TYPE 2 DIABETIC WOMEN. Ali, Shatha H.; Ahmed Ali, Abdul-Rahim; Al-Luhaibi, Khalid Ibrahim // International Journal of Advanced Biological Research;2014, Vol. 4 Issue 1, p52 

    There are several evidences that IGF-1 is a potent regulator of androgen production in mammalian theca cells, and estradiol synthesis by human granulosa and luteal cells. The association of obesity with some hormonal disorders in females could be attributed to altered metabolism in relation to...

  • Influence of Testosterone Replacement Therapy on Metabolic Disorders in Male Patient with Type 2 Diabetes Mellitus and Androgen Deficiency. Janjgava, Shota; Zerekidze, Tamar; Uchava, Lasha; Giorgadze, Elene; Asatiani, Ketevan // Macedonian Journal of Medical Sciences;12/15/2014, Vol. 7 Issue 4, p601 

    INTRODUCTION: Multiple epidemiological studies have shown that low testosterone levels are associated with and predict the future development of T2DM. AIM: The aim of study was to show the influence of testosterone replacement therapy on anthropometric characteristics, glycosylated...

  • The Evaluation of Serum Levels of Testosterone in Type 2 Diabetic Men and Its Relation with Lipid Profile. MATTACK, NIRMALI; DEVI, RUNI; KUTUM, TRIDIP; PATGIRI, DIBYARATNA // Journal of Clinical & Diagnostic Research;Jan2015, Vol. 9 Issue 1, p4 

    Introduction and Aim: Type 2 diabetes mellitus (T2DM) is the predominant form of diabetes worldwide and much is known about its patho-physiology. Yet, newer aspects related to it are being constantly explored. For ages, testosterone has been known to men as the male sex hormone but now it has...

  • Chromium Picolinate Does Not Improve Key Features of Metabolic Syndrome in Obese Nondiabetic Adults. Nayyar Iqbal; Serena Cardillo; Sheri Volger; LeAnne T. Bloedon; Richard A. Anderson; Raymond Boston; Philippe O. Szapary // Metabolic Syndrome & Related Disorders;Apr2009, Vol. 7 Issue 2, p143 

    Background:The use of chromium-containing dietary supplements is widespread among patients with type 2 diabetes. Chromium’s effects in patients at high risk for developing diabetes, especially those with metabolic syndrome, is unknown. The objective of this study was to determine the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics